featured
Efficacy of Sintilimab Plus Bevacizumab Combined With Radiotherapy in Patients With Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Hepatology (Baltimore, Md.)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Sintilimab plus bevacizumab combined with radiotherapy as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter, single-arm, phase 2 study
Hepatology 2024 Oct 01;80(4)807-815, M Zhu, Z Liu, S Chen, Z Luo, J Tu, L Qiao, J Wu, W Fan, Z PengFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.